Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

group

group is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 124
News articles 0
Drug details — group
Class
—
Route
—
Patents
20
Programs
124
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

group is an FDA-listed pharmaceutical active ingredient.

Key facts

INN group

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 10-week smoking cessation group therapy combined with NicoDerm CQ Phase 3 · BRIGHT MINDS BIOSCIENCES · Tobacco Use Cessation
  2. 2.16/VI/22 Phase 3 · Cardiol Therapeutics · Patients with functionally single ventricle (FSV - functiona
  3. 20190531 Phase 3 · Amgen · Behçet’s disease is a chronic, relapsing, multisystem inflam
  4. 220030 Phase 3 · GSK Glaxo Smith · Invasive meningococcal disease (IMD)
  5. Azacitidine Combined With Venetoclax and ATRA group Phase 3 · First People's Hospital · Acute Myeloid Leukemia
  6. C1091009 Phase 3 · First Biotech (Australia) · Group B streptococcus (GBS) disease
  7. GN41791 Phase 3 · HOFFMANN-LA ROCHE · Primary Progressive Multiple Sclerosis (PPMS)
  8. MCT8-2021-3 Phase 3 · Rare Thyroid Therapeutics · Monocarboxylate Transporter 8 (MCT8) deficiency

Related patents

Browse patents

  1. WO 2026029046

    LIPIDE D'URÉE OU DE CARBAMATE AYANT UN GROUPE CYCLIQUE DANS UNE CHAÎNE LATÉRALE, NANOPARTICULES LIPIDIQUES DE CELUI-CI ET COMPOSITION PHARMACEUTIQUE ASSOCIÉE

    Expires Wed Jan 31 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11813358

    Lipid nanodisc formation by polymers having a pendant hydrophobic group

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11793871

    Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11338033

    Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof

    Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11191778

    Multifunctional linker technology containing an N4 group

    Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. AU 2019294474

    Pyridine derivatives substituted by heterocyclic ring and amino group

    Expires Wed Feb 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10760078

    Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

    Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10441607

    Multifunctional linker technology containing an N4 group

    Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10428200

    Immobilization of an active agent on a substrate using compounds including trihydroxyphenyl groups

    Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10202602

    Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

    Expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10072122

    Carbonate polymer containing a functional group of disulfide five-membered ring in the side chain and application thereof

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9950001

    Polynucleotides having bioreversible groups

    Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9708310

    Phenanthroindolizidine and phenanthroquinolizidine alkaloid having a hydroxyl group on the phenanthrene ring thereof, preparation method and use thereof

    Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9655917

    Immobilization of an active agent on a substrate using compounds including trihydroxyphenyl groups

    Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9650447

    Complement receptor 2 (CR2) targeting groups

    Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9469664

    Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

    Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9180196

    Photodegradable groups for tunable polymeric materials

    Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9169296

    Expression and assembly of human group C rotavirus-like particles and uses thereof

    Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9067961

    Thiocarbon-protecting groups for RNA synthesis

    Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9056127

    Hydrogel composition based on co-polymer carrying multiple pendant sulphonic groups for use as a wound dressing

    Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is group?

group is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.